PRP Versus HA IN OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT
ConditionPatellofemoral Osteoarthritis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-65
SponsorIstituto Ortopedico Rizzoli
About this trial
The aim of the study is to compare the 12-month clinical outcomes of patients with patellofemoral osteoarthritis undergoing infiltrative treatment with fresh PRP and HA
Eligibility criteria
Qualifiers
Age between 30 and 65;
Signs and symptoms of isolated patellofemoral osteoarthritis present in one or both knees;
Radiographic signs of isolated patellofemoral osteoarthritis (according to Iwano et al stage 1-3 classification) or chondropathy (assessed on MRI) with K-L grade of the other compartments ≤ 2. [PMID: 2302884 - PMID: 27979409] ;
Hemoglobin > 11 g/dl; Platelet count > 150,000 plt/mm3 (Recently performed CBC exam);
Disqualifiers
Patients unable to express consent;
Patients who have undergone intra-articular infiltration of another substance within the previous 6 months;
Patients undergoing knee surgery within the previous 12 months;
Patients with malignant neoplasms;
Trial design
Treatments tested in this trial
- Autologous PRP injection
- HA injection
Treatment groups
166 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov